Literature DB >> 14700711

The price of prevention. cost of recommended activities to improve immunizations.

John Fontanesi1, Michelle De Guire, David Kopald, Kathy Holcomb.   

Abstract

PURPOSE: To calculate the cost structure of a suite of immunization improvement interventions recommended by the Centers for Disease Control and Prevention (CDC).
METHODS: A determination was made of the cost to clinics and agencies that implement a suite of CDC-recommended practice improvement interventions to fully immunize a child for diphtheria-tetanus-attenuated pertussis (DTaP), inactivated poliovirus (IPV), and measles-mumps-rubella (MMR) vaccines. Patient data were collected through chart analysis of 16-month-old children in clinics participating in this study's interventions between May 1997 and August 2000. The study began on October 1, 1996, and was funded for 5 years (until September 30, 2002).
RESULTS: Study calculations suggest that an additional $0.013/per patient per month would be needed to cover these activities.
CONCLUSIONS: Identifiable cost structures are associated with the practice improvement strategies recommended by the CDC. The method of implementation may be as important as the interventions themselves. Present compensation for immunization may not actually cover the cost of service provision, and it is unlikely to cover the costs of practice improvement, as described in this paper.

Entities:  

Mesh:

Year:  2004        PMID: 14700711     DOI: 10.1016/j.amepre.2003.09.009

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  4 in total

1.  Cost-effectiveness of Interventions to Increase HPV Vaccine Uptake.

Authors:  Jennifer C Spencer; Noel T Brewer; Justin G Trogdon; Morris Weinberger; Tamera Coyne-Beasley; Stephanie B Wheeler
Journal:  Pediatrics       Date:  2020-11-16       Impact factor: 7.124

Review 2.  Increasing Coverage of Appropriate Vaccinations: A Community Guide Systematic Economic Review.

Authors:  Verughese Jacob; Sajal K Chattopadhyay; David P Hopkins; Jennifer Murphy Morgan; Adesola A Pitan; John M Clymer
Journal:  Am J Prev Med       Date:  2016-02-01       Impact factor: 5.043

Review 3.  Health economics of rubella: a systematic review to assess the value of rubella vaccination.

Authors:  Joseph B Babigumira; Ian Morgan; Ann Levin
Journal:  BMC Public Health       Date:  2013-04-29       Impact factor: 3.295

4.  Heterogeneity Between States in the Health and Economic Impact of Measles Immunization in the United States.

Authors:  Angel Paternina-Caicedo; Julia Driessen; Mark Roberts; Willem Gijsbert van Panhuis
Journal:  Open Forum Infect Dis       Date:  2018-06-16       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.